A Comparative Study of the Prognosis of Patients Undergoing Thoracoscopic Lung Surgery with a History of SARS-CoV-2 Infection
Objective To investigate the clinical characteristics and factors affecting prognosis in patients with a history of SARS-CoV-2 infection undergoing pulmonary surgery.Methods A retrospective comparative study was conducted on the clinical information of patients who underwent elective thoracoscopic lung surgery at the Capital Medical University Power Teaching Hospital from July 2022 to April 2023.According to whether the patients were infected with SARS-CoV-2 in their past medical history,all the cases were divided into two groups:the SARS-CoV-2 infection group and the SARS-CoV-2 non-infection group.Compare the general information,surgical data,and clinical outcomes of the two groups of patients,and analyze the risk factors that affect the length of hospitalization for patients with previous novel coronavirus infection.Results There were 198 patients included in this study,97 in the infected group and 101 in the non-infected group.There was no significant difference in general information,surgical data,postoperative ICU admission rate,postoperative mortality,and postoperative hospitalization time between the two groups of patients ( P>0.05 ) .The most common postoperative complication was respiratory tract infection,but the difference was not statistically significant ( P>0.05 ) .Multiple logistic regression analysis showed that there was no collinearity among all variables ( VIF<10 ),and pulmonary complications were an independent risk factor for postoperative hospital stay.Conclusion Thoracoscopic lung surgery performed 8 weeks after recovery from SARS-CoV-2 infection does not affect surgical outcomes,nor does it increase the incidence of postoperative complications.The primary factor influencing postoperative hospital stay was pulmonary complications.